cerium has been researched along with Cerebral Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; E, Y; Huang, Z; Liang, J; Qi, Y; Qian, K; Zhao, L | 1 |
| Chi, JS; Jia, JJ; Li, CY; Li, JZ; Liu, XM; Yi, L; Zhang, J; Zhang, T; Zhou, D | 1 |
2 other study(ies) available for cerium and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
A biomimetic zeolite-based nanoenzyme contributes to neuroprotection in the neurovascular unit after ischaemic stroke via efficient removal of zinc and ROS.
Topics: Animals; Biomimetics; Blood-Brain Barrier; Brain Ischemia; Cerium; Infarction, Middle Cerebral Artery; Ischemic Stroke; Neuroprotection; Rats; Reactive Oxygen Species; Reperfusion Injury; Stroke; Zeolites; Zinc | 2022 |
Combination Therapy with LXW7 and Ceria Nanoparticles Protects against Acute Cerebral Ischemia/Reperfusion Injury in Rats.
Topics: Animals; Antioxidants; Apoptosis; Blood-Brain Barrier; Cerium; Drug Combinations; Infarction, Middle Cerebral Artery; Male; Nanoparticles; Neuroprotective Agents; Oxidative Stress; Peptides, Cyclic; Rats; Rats, Sprague-Dawley | 2018 |